Abstract:Background Hepatopulmonary syndrome (HPS) is characterized by advanced liver disease, hypoxemia and intrapulmonary vascular dilatation (IPVD). The pathogenesis of HPS is not completely understood. Recent findings have established the role of proliferation and phenotype differentiation of pulmonary microvascular endothelial cells (PMVECs) in IPVD of HPS; the change in cytoskeletal proteins and their molecular mechanism play an essential role in the proliferation, phenotype modulation and differentiation of PMVECs. However, little is known about the relevance of cytoskeletal protein expression and its molecular mechanism in IPVD of HPS. In addition, ANX A1 protein has been identified as a key regulator in some important signaling pathways, which influences cytoskeletal remodeling in many diseases, such as lung cancer, liver cancer, etc. Methods PMVECs were cultured from the normal rats and then divided into three groups(Ad-ANXA1-transfected group, a non-transfected group, and an adenovirus empty vector group) and incubated by nomal rat serum or hepatopulmonary syndrome rat serum respectively. mRNA level was evaluated by real time reverse transcription polymerase chain reaction, and protein expression was detected by western blot. Cell proliferation was determined by the MTT and thymidine incorporation assay. Results In this study, we found that the serum from a common bile duct ligation(CBDL) Rat model decreased the expression levels of the ANX A1 mRNA and protein by at least two-fold in human PMVECs. We also found the expression of cytoskeletal proteins (Destrin, a1-actin, and a1-tubulin) in PMVECs significantly increased. After stimulating ANX A1 over-expression in PMVECs by adenovirus-mediated ANX A1 (Ad-ANXA1) transfection, we found the expression levels of cytoskeletal proteins were significantly suppressed in PMVECs at all time points. Additionally, we report here that serum from a CBDL Rat model increases the proliferation of PMVECs by nearly two-fold and that over-expression of Ad-ANXA1 significantly inhibits HPS-rat-serum-induced PMVEC proliferation ( p <0.05). These findings suggest that the ANX A1 down-regulation of PMVEC proliferation in the presence of HPS-rat-serum may be the major cause of aberrant dysregulation of cytoskeletal proteins (Destrin, a1-actin, and a1-tubulin) and may, therefore, play a fundamental role in the proliferation and phenotype differentiation of PMVECs in the PVD of HPS. Conclusion Finally, the fact that transfection with Ad-ANXA1 results in inhibition of the aberrant dysregulation of cytoskeletal proteins and proliferation of PMVECs suggests a potential therapeutic effect on PVD of HPS.

AMD3100 Treatment Attenuates Pulmonary Angiogenesis by Reducing the C-Kit (+) Cells and Its Pro-Angiogenic Activity in CBDL Rat Lungs.

Interruption of CD40 Pathway Improves Efficacy of Transplanted Endothelial Progenitor Cells in Monocrotaline Induced Pulmonary Arterial Hypertension.

Effect of AMD3100 on the Proliferation and Angiogenesis of AsPC-1 Cells

The Angiogenic Related Functions of Bone Marrow Mesenchymal Stem Cells Are Promoted by CBDL Rat Serum Via the Akt/Nrf2 Pathway.

Quercetin Alleviates Pulmonary Angiogenesis in a Rat Model of Hepatopulmonary Syndrome

Caspase-3 Inhibition Prevents the Development of Hepatopulmonary Syndrome in Common Bile Duct Ligation Rats by Alleviating Pulmonary Injury.

Inhibition of CXCR4 ameliorates hypoxia-induced pulmonary arterial hypertension in rats.

Intervention of AMD3100 in lung tissues of rats during pulmonary oxygen intoxication

AMD3100 Mobilizes Endothelial Progenitor Cells in Mice, but Inhibits Its Biological Functions by Blocking an Autocrine/Paracrine Regulatory Loop of Stromal Cell Derived Factor-1 in Vitro

Vildagliptin Ameliorates Intrapulmonary Vasodilatation and Angiogenesis in Chronic Common Bile Duct Ligation-Induced Hepatopulmonary Syndrome in Rat

AMD3100 Inhibits Epithelial–mesenchymal Transition, Cell Invasion, and Metastasis in the Liver and the Lung Through Blocking the SDF‐1α/CXCR4 Signaling Pathway in Prostate Cancer

Inhibition of Autophagy Ameliorates Pulmonary Microvascular Dilation and PMVECs Excessive Proliferation in Rat Experimental Hepatopulmonary Syndrome

The Effects of Ginsenoside Compound K on Pulmonary Arterial Hypertension Rats: Suppression of Vascular Remodeling and Inhibiting NF-κB/NLRP3 Inflammasome Signalling

Annexin A1 Protein Regulates the Expression of PMVEC Cytoskeletal Proteins in CBDL Rat Serum-Induced Pulmonary Microvascular Remodeling

AOS ameliorates monocrotaline-induced pulmonary hypertension by restraining the activation of P-selectin/p38MAPK/NF-κB pathway in rats.

Elevated circulating BMP9 aggravates pulmonary angiogenesis in hepatopulmonary syndrome rats through ALK1‐Endoglin‐Smad1/5/9 signalling

AMD3100 reduces CXCR4-mediated survival and metastasis of osteosarcoma by inhibiting JNK and Akt, but not p38 or Erk1/2, pathways in in vitro and mouse experiments.

Selective Enhancement of Donor Hematopoietic Cell Engraftment by the CXCR4 Antagonist AMD3100 in a Mouse Transplantation Model

Ginsenoside Compound K Attenuates Pulmonary Arterial Hypertension.

The Therapeutic Effects of Baicalein on the Hepatopulmonary Syndrome in the Rat Model of Chronic Common Bile Duct Ligation

CXCR4 antagonist AMD3100 enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma